LATEST NEWS
Review of The National Biofilms Innovation Centre (NBIC) Showcase Event
Thank you to National Biofilm Innovation Centre (NBIC) for another really impressive showcase event on 12 September 2023. We were lucky enough to be there in 2017 at the NBIC launch event and we have been continually impressed and supportive of their endeavours to...
New Standard Notification – ISO 4768:2023
New Standard Notification – ISO 4768:2023 the measurement of anti-biofilm activity on plastic and other non-porous surfaces was released this month.
This marks a key progressive step in anti-biofilm testing standards. The method is to support material development and...
Testing Solutions to Support Medical Device Innovation
New and novel products are a necessity in the medical device market. Industry investment in innovation delivers life enhancing healthcare devices, diagnostics, and digital solutions. Hand-in-hand with product innovation is its innovative test methods, to support efficacy...
Biofilm Spotlight Interview – Dr Philip Bowler
We are once again supporting the NBIC Biofilm Week 2022 campaign, highlighting research to prevent, detect, manage, and engineer biofilms.
Perfectus Biomed Group, now part of NAMSA, are thrilled to take this opportunity to launch our Biofilm Spotlight Interview Series....
Viral Inactivation and Disinfection of Medical Devices according to EN ISO 22442
In order to ensure medical devices are safe for use, regulatory bodies require manufacturers to demonstrate adequate inactivation and removal of viruses. Perfectus Biomed, now part of NAMSA, can help you with this key validation step.
A crucial element in the product...
Perfectus Biomed Group are delighted to announce that we are now a part of NAMSA
NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its acquisition of Perfectus Biomed Group, a UK founded laboratory, providing customized microbiological services.
“Perfectus Biomed Group...
Efficacy tests to justify claims against the monkeypox virus
What is Monkeypox?
On the 23rd July 2022, the World Health Organisation declared the spread of monkeypox as a public health emergency of international concern. Countries in Europe have recorded high cases, but there have also been reports in the US, Canada, Australia,...
Navigating ISO 10993 and Successfully Applying Framework to Innovative Medical Device Manufacturing
What is ISO 10993?
ISO 10993 sets out a series of standards for evaluating the biocompatibility of medical devices to manage biological risk. ISO defines biocompatibility as the “ability of a medical device or material to perform with an appropriate host response in a...
Another UKAS ISO 17025 accredited method – Quantification of Biofilm using an ex vivo Burn Wound Model
We are thrilled to announce that we have recently received UKAS ISO 17025 accreditation for our ex vivo tissue Burn Wound Model. This latest accreditation adds to our impressive list of accredited biofilm methods, both in vitro and ex vivo. Well done to our fantastic,...